Europe
The Award recognizes Patient Entrepreneurs demonstrating outstanding innovations which advance solutions in the prevention, management or care of cancer
Adrenomed AG, the vascular integrity company, announced that its Supervisory Board has appointed two new members of the Executive Board.
The 25th annual BIO-Europe® global life sciences partnering event will be held November 11–13, 2019, in Hamburg, Germany, supported by regional hosts Life Science Nord, the City of Hamburg, and the State of Schleswig-Holstein.
Ergomed plc will announce its interim results for the six months ending 30 June 2019 on 25September 2019.
Vivoryon Therapeutics AG announced its financial results for the first six months of 2019 ending June 30.
AstraZeneca announced positive results from the Phase III ETHOS trial for triple-combination therapy PT010 in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).
Anthony Grosso has been appointed to the role of Head of Scientific Affairs [SA] at Accord Healthcare Europe.
The first half of the year has been characterized by continued work to develop the company’s innovative projects in two treatment areas, both of which have significant medical needs because the current treatment options are less effective or non-existent.
Human skin is home to a large number and wide variety of microorganisms such as bacteria, fungi, and viruses, collectively known as the skin microbiome.
Pneumagen Ltd announced appointments to its Scientific Advisory Board, bringing international expertise in the areas of respiratory disease, immunology and oncology.
PRESS RELEASES